Terns Pharmaceuticals Inc Ordinary Shares TERN
News
Terns Pharmaceuticals' stock soars 17% after biotech posts positive results in trial of weight-loss drug in pill form
Terns Announces Proposed Public Offering
Terns Pharmaceuticals Announces Positive Phase 1 Clinical Trial Results with TERN-601 Once-Daily Oral GLP-1R Agonist for the Treatment of Obesity
Terns Pharmaceuticals Reports Second Quarter 2024 Financial Results and Corporate Updates
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition
Mizuho still recommends Terns Pharma as a cheap entry to the weight-loss-drug craze
This small-cap stock is expected to take off - if its weight-loss pill trial succeeds